Reduced morbidity at diagnosis and improved glycemic control in children previously enrolled in DiPiS follow-up

Aims/hypothesis Children participating in longitudinal type 1 diabetes prediction studies were reported to have less severe disease at diabetes diagnosis. Our aim was to investigate children who from birth participated in the Diabetes Prediction in Skåne (DiPiS) study for metabolic status at diagnos...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pediatric diabetes Ročník 15; číslo 7; s. 494 - 501
Hlavní autoři: Lundgren, Markus, Sahlin, Åsa, Svensson, Camilla, Carlsson, Annelie, Cedervall, Elisabeth, Jönsson, Björn, Jönsson, Ida, Larsson, Karin, Lernmark, Åke, Neiderud, Jan, Vigård, Tore, Elding Larsson, Helena
Médium: Journal Article
Jazyk:angličtina
Vydáno: Former Munksgaard John Wiley & Sons A/S 01.11.2014
Témata:
ISSN:1399-543X, 1399-5448, 1399-5448
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Aims/hypothesis Children participating in longitudinal type 1 diabetes prediction studies were reported to have less severe disease at diabetes diagnosis. Our aim was to investigate children who from birth participated in the Diabetes Prediction in Skåne (DiPiS) study for metabolic status at diagnosis and then continued to be followed for 2 yr of regular clinical care. Methods Children, followed in DiPiS before diagnosis, were compared to children in the same birth cohort, who did not participate in follow‐up. Metabolic status, symptoms at diagnosis as well as hemoglobin A1c (HbA1c) and doses of insulin at 3, 6, 12, and 24 months after diagnosis were compared. Results Children, followed in DiPiS and diagnosed at 2–12 yr of age, had 0.8% (9 mmol/mol) lower HbA1c at diagnosis than those who were not followed (p = 0.006). At diagnosis, fewer DiPiS children had symptoms (p = 0.014) and ketoacidosis at diagnosis were reduced (2% compared to 18%, p = 0.005). During regular clinical care, HbA1c levels for the DiPiS children remained lower both at 12 (0.4% (4 mmol/mol); p = 0.009) and 24 months (0.8% (9 mmol/mol) p  <  0.001) after diagnosis, despite no difference in total daily insulin between the two groups. Conclusions Participation in prospective follow‐up before diagnosis of type 1 diabetes leads to earlier diagnosis with fewer symptoms, decreased incidence of ketoacidosis as well as better metabolic control up to 2 yr after diagnosis. Our data indicate that metabolic control at the time of diabetes diagnosis is important for early metabolic control possibly affecting the risk of long‐term complications.
Bibliografie:Swedish Research Council - No. 14064
Juvenile Diabetes Research Foundation
ArticleID:PEDI12151
SUS foundations
Lion Club International
istex:7C774A5E2400C40A641DE13D577EA781216B4F09
National Institutes of Health - No. DK26190
Wallenberg Foundation
SUS funds
district 101-S
Terry & Louise Gregg Diabetes in Pregnancy Award from the American Diabetes Association
Swedish Childhood Diabetes Foundation
Skåne County Council Foundation for Research and Development
Swedish Diabetes Association
ark:/67375/WNG-K37XWLB7-7
Nordisk Insulin Fund
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1399-543X
1399-5448
1399-5448
DOI:10.1111/pedi.12151